SCHEMBL529337

SCHEMBL529337

C=CCN(CC=CO)CC=CO

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526565 1.00 ALDH1A1 (0.31) ALDH1A1
SCHEMBL11500604 0.89
SCHEMBL11069859 0.84 OPRK1 (0.33) ALDH1A1
SCHEMBL10256711 0.82 TSHR (0.35) ALDH1A1
Hydrochloric Acid SCHEMBL29133447 0.82
SCHEMBL7549527 0.78 TSHR (0.43) ALDH1A1
SCHEMBL20656 0.78 TSHR (0.43) ALDH1A1
Formic Acid SCHEMBL7604832 0.77 ALDH1A1 (0.39) ALDH1A1
SCHEMBL6919007 0.76
SCHEMBL7464488 0.75 TSHR (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3199610-B1 FUEL ADDITIVES AND FUELS CONTAINING THE ADDITIVES AFTON CHEMICAL CORP (US) 2021-05-26 EP claimed
US-10011795-B1 Fuel additive mixtures and fuels containing them AFTON CHEMICAL CORPORATION (US) 2018-07-03 US claimed
EP-3199610-A1 FUEL ADDITIVES AND FUELS CONTAINING THE ADDITIVES Afton Chemical Corporation (US) 2017-08-02 EP claimed
US-9353326-B1 Synergistic fuel additives and fuels containing the additives AFTON CHEMICAL CORPORATION (US) 2016-05-31 US claimed
US-20150191493-A1 NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS Universite de Bordeaux (FR) 2015-07-09 US claimed
EP-2684887-B1 New process for preparing arylboranes by arylation of organoboron compounds UNIV BORDEAUX (FR) 2015-06-17 EP claimed
WO-2015082592-A2 METHOD FOR PREPARING AMINOARYLBORANE COMPOUNDS OR DERIVATIVES THEREOF Universite de Bordeaux (FR) 2015-06-11 WO claimed
EP-2881398-A1 Method for preparing aminoarylborane compounds or derivatives thereof Université de Bordeaux I (FR) 2015-06-10 EP claimed
EP-2684887-A1 New process for preparing arylboranes by arylation of organoboron compounds UNIVERSITE DE BORDEAUX I (FR) 2014-01-15 EP claimed
US-20120260876-A1 METHOD OF INCREASING FUEL EFFICIENCY INNOSPEC LIMITED (GB) 2012-10-18 US claimed
WO-2010139994-A1 IMPROVEMENTS IN EFFICIENCY INNOSPEC LIMITED (GB) 2010-12-09 WO claimed
EP-0869163-A1 Method for reducing engine friction MOBIL OIL CORPORATION (US) 1998-10-07 EP claimed
EP-0287818-A2 Polymerisable compounds and mixture containing them polymerisable by radiation HOECHST AKTIENGESELLSCHAFT (DE) 1988-10-26 EP claimed
EP-0027586-B1 Heat-sealable layered films from polyolefins and their use as packaging films Wolff Walsrode Aktiengesellschaft (DE) 1982-06-30 EP claimed
US-20240218173-A1 IMPROVED PROCESSES FOR PRODUCING THERMOPLASTIC ABS MOLDING COMPOSITIONS INEOS STYROLUTION GROUP GMBH (DE) 2024-07-04 US disclosed
US-11965066-B2 Thermoplastic compositions with improved UV resistance INEOS STYROLUTION GROUP GMBH (DE) 2024-04-23 US disclosed
US-20240117171-A1 BLACK STYRENE COPOLYMER COMPOSITIONS FOR HIGH GLOSS EXTERIOR APPLICATIONS INEOS STYROLUTION GROUP GMBH (DE) 2024-04-11 US disclosed
US-4408026-A Mixtures of polymers for medical use HOSPAL-SODIP, S.A. (FR) 1983-10-04 US disclosed
US-4394462-A Mixtures of polymers for medical use HOSPAL-SODIP, S.A. (FR) 1983-07-19 US disclosed
US-4096127-A Anionic polyurethanes AKZONA INCORPORATED (US) 1978-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191493-A1 NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS NISCH, BRD7, BRSK2 ALDH1A1 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.